In a 13-year-old with fever, upper respiratory tract infection signs (cough, sore throat, nasal congestion) and a diffuse maculopapular rash, could this be dengue?

Can This Be Dengue?

Dengue is unlikely in this 13-year-old with upper respiratory symptoms (cough, sore throat, nasal congestion) and diffuse maculopapular rash, because dengue typically does NOT present with prominent respiratory tract findings, and the diagnosis requires either recent travel to or residence in a dengue-endemic area. 1

Critical Epidemiologic Requirement

• Travel or residence history in a dengue-endemic area is mandatory for considering dengue—the CDC states that dengue testing should only be considered in patients with clinically compatible illness who live in or recently traveled to areas where there is risk for dengue virus infection. 1

• Without documented exposure to tropical/subtropical regions where Aedes aegypti or Aedes albopictus mosquitoes transmit dengue (Southeast Asia, Latin America, the Caribbean, Pacific Islands), the diagnosis should not be pursued. 2, 3

Why the Clinical Picture Argues Against Dengue

Respiratory Symptoms Are Atypical

• The presence of cough, sore throat, and nasal congestion strongly argues against dengue—in a Puerto Rico study differentiating dengue from other febrile illnesses, the absence of cough and sore throat were independently associated with dengue infection, meaning these respiratory symptoms make dengue less likely. 4

• The CDC differential diagnosis for dengue explicitly lists "upper respiratory tract infection signs" as features pointing toward alternative viral etiologies (adenovirus, enterovirus) rather than dengue. 1

Classic Dengue Features Are Missing

• Dengue fever characteristically presents with abrupt onset of high fever, severe frontal headache, retro-orbital pain, severe myalgia/arthralgia ("breakbone fever"), and prostration—the constellation of upper respiratory symptoms described here does not fit this pattern. 2, 3

• Retro-orbital pain was the single most consistent feature associated with dengue across all age groups in the Puerto Rico surveillance data, and its absence further reduces the likelihood. 4

• The CDC case definition for dengue requires fever plus one or more of the following: nausea, vomiting, rash, headache, retro-orbital pain, myalgia, arthralgia, positive tourniquet test, leukopenia, or dengue warning signs—upper respiratory symptoms are not part of this definition. 1

Timing and Rash Characteristics

• When dengue rash does occur, it typically appears on day 3–5 of illness as a macular or maculopapular eruption that often spares the face and extremities initially, then may involve the trunk and limbs. 5, 2

• Importantly, not all dengue cases develop a rash—one case series documented dengue without any rash, so the presence of rash alone does not confirm or exclude dengue. 6

• The diffuse distribution described here is nonspecific and could represent any viral exanthem, drug reaction, or other febrile illness. 7

Laboratory Clues That Would Support Dengue

• Leukopenia (white blood cell count < 4,000/mm³) and thrombocytopenia (platelet count < 150,000/mm³) are hallmark laboratory findings in dengue and were present in both documented dengue cases. 5, 6

• In children, thrombocytopenia combined with absence of cough was the strongest predictor of dengue in the Puerto Rico model. 4

• Elevated muscle enzymes (creatine phosphokinase) may occur with severe myalgia. 6

• If dengue is being considered, obtain a complete blood count with differential and comprehensive metabolic panel immediately. 1

What This Clinical Picture More Likely Represents

Viral Upper Respiratory Infection with Exanthem

• Viral exanthems are the most common cause of maculopapular rashes in children, particularly enteroviral infections that present with trunk and extremity involvement while sparing palms, soles, face, and scalp. 7

• Human herpesvirus 6 (roseola) presents with macular rash following resolution of high fever. 7

• Epstein-Barr virus causes maculopapular rash, especially if the patient received ampicillin or amoxicillin. 7

• Parvovirus B19 presents with "slapped cheek" appearance on the face with possible truncal involvement. 7

Other Differential Considerations

• Group A streptococcal pharyngitis (scarlet fever) should be considered given the sore throat—this presents with a sandpaper-textured rash during active fever, spreading from the upper trunk. 8

• Adenovirus and other respiratory viruses commonly cause both upper respiratory symptoms and nonspecific viral exanthems. 1

Diagnostic Algorithm

1. Obtain detailed travel history—specifically ask about travel to dengue-endemic regions in the past 2 weeks (the typical incubation period is 4–7 days). 2, 3

2. If no travel history exists, dengue testing is not indicated—pursue alternative diagnoses based on the respiratory symptoms and rash morphology. 1

3. If travel history is positive, obtain:

   • Complete blood count with differential (looking for leukopenia, thrombocytopenia) 5, 6
   • Comprehensive metabolic panel 1
   • Dengue NS1 antigen test and/or RT-PCR if within 7 days of symptom onset 1, 5
   • Dengue IgM antibody testing if >7 days from symptom onset 1

4. Assess for warning signs of severe dengue—abdominal pain, persistent vomiting, clinical fluid accumulation, mucosal bleeding, lethargy/restlessness, liver enlargement, or rising hematocrit with falling platelets. 2, 3

Critical Pitfall to Avoid

• Do not pursue dengue testing in the absence of epidemiologic risk—the positive predictive value of any dengue test is extremely low in non-endemic areas without travel history, and false-positive results can lead to misdiagnosis and inappropriate management. 1